These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 33527138)
1. Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma. Laskar RS; Li P; Ecsedi S; Abedi-Ardekani B; Durand G; Robinot N; Hubert JN; Janout V; Zaridze D; Mukeria A; Mates D; Holcatova I; Foretova L; Swiatkowska B; Dzamic Z; Milosavljevic S; Olaso R; Boland A; Deleuze JF; Muller DC; McKay JD; Brennan P; Le Calvez-Kelm F; Scelo G; Chanudet E Hum Mol Genet; 2021 Apr; 30(5):343-355. PubMed ID: 33527138 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma. Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D Front Immunol; 2021; 12():734646. PubMed ID: 34795663 [TBL] [Abstract][Full Text] [Related]
3. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis. Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448 [TBL] [Abstract][Full Text] [Related]
8. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm. Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552 [TBL] [Abstract][Full Text] [Related]
14. Gene signatures of progression and metastasis in renal cell cancer. Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910 [TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749 [TBL] [Abstract][Full Text] [Related]
16. The miR-200 family as prognostic markers in clear cell renal cell carcinoma. Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993 [TBL] [Abstract][Full Text] [Related]
17. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272 [TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920 [TBL] [Abstract][Full Text] [Related]
19. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma. Zhang Y; Yuan Y; Liang P; Guo X; Ying Y; Shu XS; Gao M; Cheng Y Oncotarget; 2017 May; 8(18):30008-30018. PubMed ID: 28404905 [TBL] [Abstract][Full Text] [Related]
20. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis. Zhang S; Fang J; Zhang X; Qin C; Su S; Deng Y; Song Z; Zhang Y; Wang H; Yin C; Wang Z Tumour Biol; 2014 Sep; 35(9):9095-100. PubMed ID: 25027395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]